Work

A phase IB trial of 5-azacitidine (5AC) and suberoylanilide hydroxamic acid (SAHA) in patients with metastatic or locally recurrent nasopharyngeal carcinoma (NPC) and NK-T cell lymphoma.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.e17017

Authors: Wen Son Hsieh, Eng Huat Tan, Wan-Teck Lim, Ross A. Soo, Anthony T. C. Chan, Edwin P. Hui, Soo-Chin Lee, John Soon Wah Low, Pei Li Lim, Thomas Kwok Seng Loh, Matthew M. Ames, Joel M. Reid, Paul Gerard Murray, Qian Tao, Boon C. Goh, Richard F. Ambinder

Institutions: Cancer Science Institute of Singapore, National Cancer Centre Singapore, National University Health System, Chinese University of Hong Kong, Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota), University of Birmingham, Johns Hopkins University

Language: English

Topic: Epigenetics and DNA Methylation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2600107722

Cites:

Cited by: 1

Related to: 10